Photo: Scientists are hunting covid-19 vaccine
Thursday, June 30, 2020
UPDATimes - According to Sky News, one of the biotechnology companies in Beijing, Sinovac, has now reached stage 2 of the Corona vaccine trial.
⠀
More than a thousand volunteers have participated in the development of the vaccine. Sinovac is also designing a vaccine development to the third or final stage.
⠀
"Yes, yes. It will definitely work, 99 percent (surely)," Luo Baishan, a Chinese researcher at Sinovac, was quoted by Sky News on Saturday (05/30/2020).
⠀
Last month, Sinovac published the results of the Corona vaccine trial in the journal Science. They reported that a vaccine called CoronaVac was able to protect monkeys from Covid-19 infection.
⠀
Now, the biggest problem facing the company is finding volunteers lanaran number of cases of Covid-19 in China has fallen significantly.
⠀
For Phase 3 trials, Sinovac even plans to move the research site to a European country. The UK will be chosen, because of the high number of infections in Covid-19 cases there.
⠀
"We spoke with several European countries and I think I also discussed with Britain," said Helen Yang, senior director of Sinovac investor relations.
⠀
"Right now is a very early stage for discussion."
⠀
Although the trials have not yet been completed, Sinovac is reportedly building a factory to produce large quantities of vaccines. The factory is located in the northwest of Beijing.
⠀
They hope to produce about 100 million doses. The amount that is not much compared to the world population, is recognized to make the vaccine distribution limited.
⠀
"This is our recommendation that it is not the entire population that gets the vaccine," Yang said.
⠀
"We first target high-risk groups, for example, health workers or senior citizens, who may have higher mortality rates."
⠀
"I think it will be the starting point. To be honest, vaccines need to be produced a lot," he said.
0 Comments